Dermatology
| Hidradenitis Suppurativa
Dermatology
Hidradenitis Suppurativa
Semaglutide for weight loss in obese patients as an adjunctive treatment for hidradenitis suppurativa: its impact on disease control and quality of life
book_2
Source:
EADV 2024 - Poster session
calendar_today
Published on Medfyle:
October 2024
In this medfyle
Hidradenitis suppurativa is a debilitating condition with an inflammatory component – and a link to obesity. New data presented at EADV 2024 explore the role of modern weight-loss options to help improve quality of life and reduce flares.
About this Medfyle
Read more
arrow_downward
Hide
arrow_upward
©2024 Infomedica-Medfyle. All rights reserved.
Source: Semaglutide for weight loss in obese patients as an adjunctive treatment for hidradenitis suppurativa: its impact on disease control and quality of life. Lyons D, et al. Presented at EADV 2024; P0111; Abstract #4457.
The information and data provided is for information purposes only. The author(s) of the original original presentation had no involvement in the creation of this content.
